home / stock / crbu / crbu short
Short Information | Caribou Biosciences Inc. (NASDAQ:CRBU)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 4,055,950 |
Total Actual Volume | 30,911,907 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 202,798 |
Average Short Percentage | 13.34% |
Is there a CRBU Short Squeeze or Breakout about to happen?
See the CRBU Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-06-2024 | $3.85 | $3.83 | $3.93 | $3.76 | 1,571,752 | 278,809 | 17.74% |
05-03-2024 | $3.77 | $3.77 | $3.9 | $3.69 | 1,817,389 | 279,983 | 15.41% |
05-02-2024 | $3.75 | $3.64 | $3.82 | $3.56 | 2,348,641 | 307,324 | 13.09% |
05-01-2024 | $3.65 | $3.69 | $3.85 | $3.61 | 1,739,878 | 203,456 | 11.69% |
04-30-2024 | $3.76 | $3.63 | $3.76 | $3.61 | 1,473,220 | 155,971 | 10.59% |
04-29-2024 | $3.74 | $3.78 | $3.895 | $3.71 | 1,476,646 | 176,042 | 11.92% |
04-26-2024 | $3.9 | $3.71 | $3.9 | $3.69 | 1,044,964 | 126,647 | 12.12% |
04-25-2024 | $3.8 | $3.76 | $3.84 | $3.71 | 1,632,852 | 270,911 | 16.59% |
04-24-2024 | $4 | $3.85 | $4.04 | $3.8 | 955,214 | 201,909 | 21.14% |
04-23-2024 | $4 | $3.98 | $4.21 | $3.98 | 926,550 | 114,385 | 12.35% |
04-22-2024 | $3.89 | $3.99 | $4.075 | $3.8 | 1,384,845 | 152,242 | 10.99% |
04-19-2024 | $3.9 | $3.85 | $4.03 | $3.78 | 1,713,612 | 242,863 | 14.17% |
04-18-2024 | $3.88 | $3.91 | $4.015 | $3.875 | 1,415,632 | 266,136 | 18.8% |
04-17-2024 | $4.05 | $3.91 | $4.09 | $3.85 | 1,998,823 | 232,072 | 11.61% |
04-16-2024 | $4.08 | $4.01 | $4.12 | $3.965 | 1,272,522 | 184,683 | 14.51% |
04-15-2024 | $4.17 | $4.07 | $4.3899 | $4.03 | 1,609,088 | 209,680 | 13.03% |
04-12-2024 | $4.37 | $4.2 | $4.37 | $4.12 | 1,962,628 | 167,355 | 8.53% |
04-11-2024 | $4.42 | $4.33 | $4.42 | $4.275 | 950,236 | 97,722 | 10.28% |
04-10-2024 | $4.39 | $4.35 | $4.44 | $4.205 | 2,135,306 | 193,636 | 9.07% |
04-09-2024 | $4.4 | $4.46 | $4.59 | $4.33 | 1,482,109 | 194,124 | 13.1% |
News, Short Squeeze, Breakout and More Instantly...
Caribou Biosciences Inc. Company Name:
CRBU Stock Symbol:
NASDAQ Market:
-- Advancing CB-010 ANTLER Phase 1 trial in 2L LBCL; initial dose expansion data to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting -- -- Expanding into autoimmune diseases with IND cleared for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Pha...
NEW YORK, April 27, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigat...
BERKELEY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstracts have been accepted for poster presentations at the 2024 American Society of Clinical Oncology (ASC...